# OnCo record liger-hn1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/liger-hn1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "liger-hn1", "NCT06525220" ;
  schema:name "LiGeR-HN1"@en ;
  schema:description "Tests whether a two-armed antibody against EGFR and a stem-cell marker can lift first-line immunotherapy results in head and neck cancer."@en ;
  schema:url <https://onco.cc/trials/liger-hn1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06525220> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2024-09-25" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/terms/lgr5/> ;
  onco:drugs <https://onco.cc/drugs/petosemtamab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/merus/>, <https://onco.cc/companies/genmab/> .